Tsuruha : Presentation Materials with Script for the Second Quarter of the Fiscal Year Ending May 15, 2021

TSURUHA HOLDINGS INC.

2nd Quarter of FY5/21 Financial Results Announcement

December 15, 2020

Event Summary

[Company Name]	TSURUHA HOLDINGS INC.
[Company ID]	3391-QCODE
[Event Language]	JPN
[Event Type]	Earnings Announcement
[Event Name]	2nd Quarter of FY5/21 Financial Results Announcement
[Fiscal Period]	FY2020 Q2
[Date]	December 15, 2020
[Number of Pages]	33
[Time]	15:30 - 16:32
	(Total: 62 minutes, Presentation: 24 minutes, Q&A: 38 minutes)
[Venue]	Webcast
[Venue Size]
[Participants]
[Number of Speakers]	3
	Jun Tsuruha	President and Representative Director
	Makoto Murakami	Executive Officer and Chief Administrative
		Officer
	Takuya Yamazaki	Investor Relations Manager
[Analyst Names]*	Dairo Murata	JPMorgan Securities Japan Co., Ltd.
	Mitsuru Takayanagi	USB Securities Japan Co., Ltd.
	Takashi Yanahira	Ichiyoshi Research Institute Inc.
	Sho Kawano	Goldman Sachs Japan Co., Ltd.
	Toshio Takahashi	Mizuho Securities Co., Ltd.

*Analysts that SCRIPTS Asia was able to identify from the audio who spoke during Q&A.

Support
Japan	03.4405.3160	North America	1.800.674.8375
Tollfree	0120.966.744	Email Support	[e-mail]

1

Presentation

Yamazaki: Now, it's time to start a briefing on TSURUHA HOLDING INC.'s financial results for the second quarter of the fiscal year ending May 15, 2021.

Let me introduce today's speakers. Jun Tsuruha, President and Representative Director.

Tsuruha: Hello, everyone. This is Jun Tsuruha.

Yamazaki: Makoto Murakami, Executive Officer and Chief Administrative Officer.

Murakami: Hello, everyone. This is Makoto Murakami.

Yamazaki: I am Takuya Yamazaki, Investor Relations Manager. I am today's moderator.

At today's briefing, we will explain our financial results briefing materials while sharing them on a screen. Please also refer to the Company's financial results briefing materials, supplementary materials, and brief summary for the financial results on the Company's website.

For today's presentation, first, Murakami will explain the outline of our business performance, followed by a briefing from Tsuruha about initiatives and policies for the fiscal year under review. Thereafter, we will move on to a question-and-answer session. At the Q&A session, we will use the Raise Hand function in Zoom and have the nominated person to ask questions.

Now, we will move on to the financial results briefing. Thank you.

Murakami: This is Murakami, Chief Administrative Officer.

I would like to explain the outline of our business performance. I will explain the financial results in accordance with the briefing materials that we distributed.

Support
Japan	03.4405.3160	North America	1.800.674.8375
Tollfree	0120.966.744	Email Support	[e-mail]

2

Please refer to page three. First, let me explain the outline of the cumulative second quarter financial results.

The figures include the three-month results from June 1 to August 31 of JR Kyushu Drug Eleven Co., Ltd., which joined the Group in May of this year.

Sales came in at JPY453.4 billion and operating income at JPY27.9 billion. We believe that they were very favorable results in comparison with both the year-before results and our forecast.

The main reasons for the results were the continuation of demand related to COVID-19 and the fact that the reaction to last-ditch demand before the consumption tax hike in the previous fiscal year was less than expected. In addition to these factors, we were able to control SG&A expenses, mainly in personnel expenses, which contributed to the growth in operating income.

In addition, we are making steady progress in integrating the operations of JR Kyushu Drug Eleven, developing our new private brands, Kurashi Rhythm and Kurashi Rhythm Medical, and promoting sales of meat, fruit and vegetables, which we are expanding in the current fiscal year.

We will explain the details on the following pages.

Support
Japan	03.4405.3160	North America	1.800.674.8375
Tollfree	0120.966.744	Email Support	[e-mail]

3